{"id":432865,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2016-01-08] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:03:39.602000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-10.html?wbdisable=true","snippet":"Notice: Prescription Drug List (PDL): Multiple additions January 8, 2016 Our file number: 15-113849-759 The purpose of this Notice of Amendment is to notify the addition of Dulaglutide, Evolocumab, Lubiprostone, Nivolumab, Polidocanol and Sacubitril to both the Human and…","rawSnapshotUrl":"/api/snapshots/raw/432865","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090339/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-10.html?wbdisable=true#ha_snapshot=432865","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}